MTC Y90Alternative Names: MTC-Y90; MTC-Yttrium-90
Latest Information Update: 10 Dec 2007
At a glance
- Originator FeRx
- Mechanism of Action Ionising radiation emitters
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Liver cancer; Solid tumours
Most Recent Events
- 09 Oct 2003 Preclinical trials in Solid tumours in USA (Intra-arterial)
- 09 Oct 2003 Preclinical trials in Liver cancer in USA (Intra-arterial)